Amit Sachdev, EVP, Chief Patient Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 58 shares at $286.63 ($16K) on 2020-05-15, disclosed to the SEC on 2020-05-19.
Scheduled sale ($16k) by EVP, Chief Patient Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $274.67 | 1 | $275 | 1.7% |
| 2 | $276.21 | 3 | $829 | 5.0% |
| 3 | $278.42 | 1 | $278 | 1.7% |
| 4 | $280.34 | 10 | $3K | 17.0% |
| 5 | $281.65 | 2 | $563 | 3.4% |
| 6 | $283.01 | 5 |
| $1K |
| 8.6% |
| 7 | $284.95 | 6 | $2K | 10.4% |
| 8 | $286.63 | 11 | $3K | 19.1% |
| 9 | $287.65 | 13 | $4K | 22.7% |
| 10 | $288.36 | 6 | $2K | 10.5% |
| Total | $284.41 avg | 58 | $16K | 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |